In response, the body prioritizes central blood volume by reducing circulation to the skin, which can result in a purple-red rash appearing on the cheeks and the bridge of the nose. Shaped ...

Parents are heartbroken as a beloved nappy rash cream - Metanium Nappy Rash Ointment - is discontinued. The product, known for its quick healing properties, has been a staple in changing bags for ...

Key opinion leaders examine approaches to managing skin-related side effects, such as rash, in patients on EGFR inhibitors, highlighting strategies to address quality-of-life impacts while maintaining ...

However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in the United States live with kidney disease, but only about 10% know they ...

Skin biopsy: To do this, your dermatologist removes a small sample from your rash, so that it can be examined under a microscope. Nail biopsy: If lichen planus may be affecting one or more of your ...

They can include a rash, large areas of excessive swelling, and even bruising that lasts for several days. The inflammatory reaction of skeeter syndrome is pretty rare. For those who are allergic to ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from returning after surgery when taken with chemotherapy. It has been recommended by the National Institute for ...

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific mutations. Osimertinib can help stop cancer from returning after surgery when ...

The drug Osimertinib (Tagrisso), developed by AstraZeneca, has been shown to double survival time in specific cases and will now be routinely available following a recommendation from the National ...

The approval is based on the phase 3 MARIPOSA study, which showed that the combination therapy demonstrated superior overall survival compared to the current standard treatment, osimertinib ...

EGFR mutations, which are prevalent in cases of NSCLC, lead to abnormal cell growth, but Osimertinib works by targeting these mutated cells, aiming to prevent the cancer's return post-surgery.